Logo image of ALBIZ.PA

OBIZ SA (ALBIZ.PA) Stock Fundamental Analysis

EPA:ALBIZ - Euronext Paris - Matif - FR0014003711 - Common Stock - Currency: EUR

5.6  0 (0%)

Fundamental Rating

4

ALBIZ gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 67 industry peers in the Media industry. ALBIZ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALBIZ shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALBIZ has reported negative net income.
ALBIZ had a positive operating cash flow in the past year.
Of the past 5 years ALBIZ 4 years were profitable.
ALBIZ had a positive operating cash flow in 4 of the past 5 years.
ALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 1M -1M 2M -2M

1.2 Ratios

ALBIZ has a Return On Assets of -0.74%. This is in the lower half of the industry: ALBIZ underperforms 71.64% of its industry peers.
The Return On Equity of ALBIZ (-2.82%) is worse than 67.16% of its industry peers.
The Return On Invested Capital of ALBIZ (1.97%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.74%
ROE -2.82%
ROIC 1.97%
ROA(3y)-1.38%
ROA(5y)-0.07%
ROE(3y)-2.28%
ROE(5y)3.62%
ROIC(3y)N/A
ROIC(5y)N/A
ALBIZ.PA Yearly ROA, ROE, ROICALBIZ.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 5 -5 10 15

1.3 Margins

ALBIZ's Profit Margin has declined in the last couple of years.
ALBIZ has a Operating Margin of 0.87%. This is in the lower half of the industry: ALBIZ underperforms 64.18% of its industry peers.
In the last couple of years the Operating Margin of ALBIZ has declined.
ALBIZ's Gross Margin of 13.29% is on the low side compared to the rest of the industry. ALBIZ is outperformed by 83.58% of its industry peers.
ALBIZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.87%
PM (TTM) N/A
GM 13.29%
OM growth 3Y-11.82%
OM growth 5YN/A
PM growth 3Y-46.22%
PM growth 5YN/A
GM growth 3Y-13.91%
GM growth 5YN/A
ALBIZ.PA Yearly Profit, Operating, Gross MarginsALBIZ.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALBIZ is destroying value.
Compared to 1 year ago, ALBIZ has more shares outstanding
ALBIZ has a worse debt/assets ratio than last year.
ALBIZ.PA Yearly Shares OutstandingALBIZ.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
ALBIZ.PA Yearly Total Debt VS Total AssetsALBIZ.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

ALBIZ has an Altman-Z score of 3.12. This indicates that ALBIZ is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.12, ALBIZ belongs to the top of the industry, outperforming 94.03% of the companies in the same industry.
ALBIZ has a Debt/Equity ratio of 1.70. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.70, ALBIZ is doing worse than 70.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Altman-Z 3.12
ROIC/WACC0.29
WACC6.79%
ALBIZ.PA Yearly LT Debt VS Equity VS FCFALBIZ.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.87 indicates that ALBIZ should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.87, ALBIZ belongs to the best of the industry, outperforming 88.06% of the companies in the same industry.
ALBIZ has a Quick Ratio of 1.33. This is a normal value and indicates that ALBIZ is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.33, ALBIZ is in the better half of the industry, outperforming 77.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.33
ALBIZ.PA Yearly Current Assets VS Current LiabilitesALBIZ.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

7

3. Growth

3.1 Past

ALBIZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -580.50%.
ALBIZ shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.63% yearly.
Looking at the last year, ALBIZ shows a very strong growth in Revenue. The Revenue has grown by 185.23%.
ALBIZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 75.48% yearly.
EPS 1Y (TTM)-580.5%
EPS 3Y-20.63%
EPS 5YN/A
EPS Q2Q%-3100%
Revenue 1Y (TTM)185.23%
Revenue growth 3Y75.48%
Revenue growth 5YN/A
Sales Q2Q%204.93%

3.2 Future

The Earnings Per Share is expected to grow by 60.79% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.63% on average over the next years. This is quite good.
EPS Next Y2.85%
EPS Next 2Y63.01%
EPS Next 3Y60.79%
EPS Next 5YN/A
Revenue Next Year53.01%
Revenue Next 2Y29.12%
Revenue Next 3Y21.48%
Revenue Next 5Y14.63%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALBIZ.PA Yearly Revenue VS EstimatesALBIZ.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
ALBIZ.PA Yearly EPS VS EstimatesALBIZ.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.1 0.2 0.3 0.4

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALBIZ. In the last year negative earnings were reported.
ALBIZ is valuated rather expensively with a Price/Forward Earnings ratio of 17.54.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALBIZ is on the same level as its industry peers.
ALBIZ's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE N/A
Fwd PE 17.54
ALBIZ.PA Price Earnings VS Forward Price EarningsALBIZ.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

ALBIZ's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALBIZ is more expensive than 64.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.12
ALBIZ.PA Per share dataALBIZ.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as ALBIZ's earnings are expected to grow with 60.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y63.01%
EPS Next 3Y60.79%

0

5. Dividend

5.1 Amount

No dividends for ALBIZ!.
Industry RankSector Rank
Dividend Yield N/A

OBIZ SA

EPA:ALBIZ (3/7/2025, 7:00:00 PM)

5.6

0 (0%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.14%
Inst Owner ChangeN/A
Ins Owners59.17%
Ins Owner ChangeN/A
Market Cap32.87M
Analysts87.27
Price Target10.1 (80.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.76%
PT rev (3m)-7.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-28%
EPS NY rev (3m)-28%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-7.44%
Revenue NY rev (3m)-7.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.54
P/S 0.27
P/FCF N/A
P/OCF 60.06
P/B 2.35
P/tB N/A
EV/EBITDA 16.12
EPS(TTM)-0.08
EYN/A
EPS(NY)0.32
Fwd EY5.7%
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)0.09
OCFY1.66%
SpS20.82
BVpS2.39
TBVpS-2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.74%
ROE -2.82%
ROCE 2.72%
ROIC 1.97%
ROICexc 2.3%
ROICexgc 9.31%
OM 0.87%
PM (TTM) N/A
GM 13.29%
FCFM N/A
ROA(3y)-1.38%
ROA(5y)-0.07%
ROE(3y)-2.28%
ROE(5y)3.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-2.32%
ROICexcg growth 5YN/A
ROICexc growth 3Y-13.58%
ROICexc growth 5YN/A
OM growth 3Y-11.82%
OM growth 5YN/A
PM growth 3Y-46.22%
PM growth 5YN/A
GM growth 3Y-13.91%
GM growth 5YN/A
F-Score3
Asset Turnover2.3
Health
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Debt/EBITDA 7.61
Cap/Depr 114.93%
Cap/Sales 1.95%
Interest Coverage 250
Cash Conversion 17.44%
Profit Quality N/A
Current Ratio 1.87
Quick Ratio 1.33
Altman-Z 3.12
F-Score3
WACC6.79%
ROIC/WACC0.29
Cap/Depr(3y)67.97%
Cap/Depr(5y)167.31%
Cap/Sales(3y)1.82%
Cap/Sales(5y)5.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-580.5%
EPS 3Y-20.63%
EPS 5YN/A
EPS Q2Q%-3100%
EPS Next Y2.85%
EPS Next 2Y63.01%
EPS Next 3Y60.79%
EPS Next 5YN/A
Revenue 1Y (TTM)185.23%
Revenue growth 3Y75.48%
Revenue growth 5YN/A
Sales Q2Q%204.93%
Revenue Next Year53.01%
Revenue Next 2Y29.12%
Revenue Next 3Y21.48%
Revenue Next 5Y14.63%
EBIT growth 1Y184.04%
EBIT growth 3Y54.74%
EBIT growth 5YN/A
EBIT Next Year306.19%
EBIT Next 3Y86.37%
EBIT Next 5Y58.29%
FCF growth 1Y-57.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y187.39%
OCF growth 3Y277.76%
OCF growth 5YN/A